How Many Patients Suffering Major Trauma Would be Eligible for a Pre-hospital Transfusion

Condition(s) studied

Investigational drug(s) / intervention(s)

Data Collection: Collection of medical data from MICU intervention file and patient medical files from participating centres

Study summary

The aim of the study is to measure the number of patients being cared for by a medical team for major trauma who could benefit from a transfusion labile blood products and thus provide a scientific argument in favour of supplying labile blood products to pre-hospital

Eligibility

Primary outcome measure(s)

• Measurement of the proportion of patients being cared for a medical team for major trauma who could have benefited from a pre-hospital transfusion — At the end of the study, an average of 4 month
  The main analysis criterion will be the presence, during pre-hospital management, of a massive and immediate blood transfusion criterion measured by the ABC (Assessment of Blood Consumption) score between the arrival of the MICU and 10 minutes before arrival at the hospital. This score is used to predict the need for massive transfusion, defined in particular as the administration of 4 labile blood products within the first hour of hospital care. This score will be calculated retrospectively on the basis of data collected from the medical record at the time the patient is taken into medical care, and then every 10 minutes during the course of the care until 10 minutes after arrival at hospital. An ABC score greater than or equal to 2 indicates a probability of massive transfusion greater than 75%. We will consider a score \>= 2 as "probably requiring a pre-hospital transfusion".

Trial sites (4)

More Hôpital NOVO trials in France

Other trials for the same condition